Stay updated on NKTR-214+Radiation+Anti-PD-1 in Head & Neck Cancer Clinical Trial

Sign up to get notified when there's something new on the NKTR-214+Radiation+Anti-PD-1 in Head & Neck Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the NKTR-214+Radiation+Anti-PD-1 in Head & Neck Cancer Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    The website revision indicator was updated from v3.7.2 to v3.8.0.
    Difference
    0.1%
    Check dated 2026-11-01T15:58:00.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    An NIH banner announces updates and FAQs about federal agencies’ transition from the term “Artificial Intelligence” to “Super Intelligence.”
    Difference
    0.7%
    Check dated 2026-10-25T18:00:19.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov site footer now identifies the page as revision v3.7.2 instead of v3.7.1.
    Difference
    0.1%
    Check dated 2026-10-18T22:30:17.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    The footer revision identifier advances from v3.7.0 to v3.7.1.
    Difference
    0.1%
    Check dated 2026-10-11T22:19:56.000Z thumbnail image
  6. Check
    51 days ago
    Change Detected
    Summary
    A new study record version v3.7.0 was added and an older version v3.6.6 was removed in the revision history.
    Difference
    0.1%
    Check dated 2026-09-20T20:19:56.000Z thumbnail image
  7. Check
    72 days ago
    Change Detected
    Summary
    A new revision entry v3.6.6 was added to the study history, replacing the previous revision v3.6.5 in the version history.
    Difference
    0.1%
    Check dated 2026-08-30T21:52:54.000Z thumbnail image

Stay in the know with updates to NKTR-214+Radiation+Anti-PD-1 in Head & Neck Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the NKTR-214+Radiation+Anti-PD-1 in Head & Neck Cancer Clinical Trial page.